In 2016, US$268 million was invested in cure research, representing a significant 33 percent increase over the US$202 million invested in 2015. The public sector made up the bulk of investment at US$253 million, with philanthropies such as Aidsfonds, amfAR, the Bill and Melinda Gates Foundation, Sidaction and Wellcome Trust contributing US$13.8 million or 5 percent of overall funding. Several companies are known to have active cure research programs but this analysis was only able to obtain information from one commercial entity and thus the estimate undercounts commercial sector contributions.
Several initiatives were ongoing in 2016. Examples include a revised International AIDS Society Global Scientific Strategy for Towards a Cure; a five-year collaboration at the NIH to support cure strategies and a six-year series of investments by amfAR for discovering a broadly applicable cure.
Download the full report, Global Investment in HIV Cure Research and Development in 2016: Funding for a cure remains a priority.